Table S2 from Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors

التفاصيل البيبلوغرافية
العنوان: Table S2 from Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors
المؤلفون: Ramesh K. Ramanathan, Louie Naumovski, Daniel Afar, Edward Reilly, Lan Wang, Huibin Yue, Shekman Wong, Monica Motwani, Peter Ansell, Chia-Chi Lin, Chia Jui Yen, Yoon-Koo Kang, Ravi Salgia, Patricia LoRusso, John H. Strickler
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Additional details for MET-amplified patients with one or more postbaseline tumor assessment (n=9).
DOI: 10.1158/1535-7163.22518666
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::724d29e98782b3d44b4991678c167d4f
https://doi.org/10.1158/1535-7163.22518666
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....724d29e98782b3d44b4991678c167d4f
قاعدة البيانات: OpenAIRE
الوصف
DOI:10.1158/1535-7163.22518666